Not applicableStudy completedNCT03207997What this trial is testingMRI Quantification of Pulmonary Fibrosis in Scleroderma PatientsWho this might be right forScleroderma Assistance Publique - Hôpitaux de Paris 24
Not applicableUnknownNCT04650659What this trial is testingFunctional Exercise Tests in Patients With Systemic SclerosisWho this might be right forScleroderma, SystemicLung Diseases, InterstitialPulmonary Arterial Hypertension+1 more University of Aarhus 83
Not applicableUnknownNCT01840748What this trial is testingDevelopment and Prevention of Pulmonary Hypertension in Systemic SclerosisWho this might be right forSystemic SclerosisPulmonary Hypertension University of Paris 5 - Rene Descartes 960
Not applicableAvailableNCT04432545What this trial is testingInfusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary InvolvementWho this might be right forSystemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis Universidad de la Sabana
Not applicableWithdrawnNCT02278445What this trial is testingEvaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)Who this might be right forSystemic SclerosisPulmonary Hypertension Echosense Ltd.
Not applicableLooking for participantsNCT07817160What this trial is testingPelvic Floor Dysfunction in Pulmonary Systemic SclerosisWho this might be right forInterstitial Lung Disease With Systemic Sclerosis Biruni University 67
Testing effectiveness (Phase 2)Ended earlyNCT00581997What this trial is testingQAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic SclerosisWho this might be right forPulmonary Fibrosis Secondary to Systemic Sclerosis Novartis Pharmaceuticals 8
Not applicableStudy completedNCT03889509What this trial is testingA Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic SclerosisWho this might be right forPulmonary Arterial HypertensionSystemic Sclerosis London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 63
Testing effectiveness (Phase 2)Study completedNCT07542067What this trial is testingInfusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to TreatmentWho this might be right forSystemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis Fundación Neumologica Colombiana 1
Not applicableNot Yet RecruitingNCT06615128What this trial is testingAssessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)Who this might be right forAssessment of Serum Level of SCD25 in RA, SSc (with or Without ILD) and IPF and Its Correlation with Disease Activity Assiut University 66
Post-approval studies (Phase 4)UnknownNCT04928586What this trial is testingImmunosuppressant Combined With Pirfenidone in CTD-ILDWho this might be right forPirfenidoneConnective Tissue DiseasesInterstitial Lung Disease Qilu Hospital of Shandong University 200
Not applicableNot Yet RecruitingNCT07186439What this trial is testingPulmonary Hypertension Screening in SclerodermaWho this might be right forPHTN in Scleroderma Patients Assiut University 35
Testing effectiveness (Phase 2)Study completedNCT02370693What this trial is testingComparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary FibrosisWho this might be right forLung Diseases, InterstitialSystemic SclerosisScleroderma Northwestern University 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06329401What this trial is testingA Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisWho this might be right forPulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more Avalyn Pharma Inc. 375
Not applicableStudy completedNCT03438032What this trial is testingIdentifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILDWho this might be right forFibrosis LungSystemic Sclerosis Northwestern University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05785065What this trial is testingMycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung DiseaseWho this might be right forSystemic Sclerosis With Lung InvolvementSystemic SclerosisInterstitial Lung Disease Centre hospitalier de l'Université de Montréal (CHUM) 35
Large-scale testing (Phase 3)Study completedNCT02597933What this trial is testingA Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung FibrosisWho this might be right forScleroderma, Systemic Boehringer Ingelheim 580
Not applicableNot Yet RecruitingNCT07393217What this trial is testingCorrelation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)Who this might be right forRheumatoid Arthritis (RA)Systemic Sclerosis (SSc) Sohag University 111
Testing effectiveness (Phase 2)Looking for participantsNCT06434363What this trial is testingPhase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune DisordersWho this might be right forAutoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more M.D. Anderson Cancer Center 47
Not applicableStudy completedNCT05505617What this trial is testingNitric Oxide Lung Diffusing Capacity in Systemic SclerosisWho this might be right forSystemic Sclerosis Holger Dressel 9